Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Peiris

Showing results (201-210 of 661) with videos related to

Pageof 67
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 14, 2017
Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017Min Kang, Eric H Y Lau, Wenda Guan, et al.
Emerging Infectious Diseases|February 7, 2008
Poultry drinking water used for avian influenza surveillanceY H Connie Leung, Li-Juan Zhang, Chun-Kin Chow, et al.
Frontiers in Veterinary Science|October 21, 2016
MERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion ElicitationAnna L Funk, Flavie Luce Goutard, Eve Miguel, et al.
The Journal of Infectious Diseases|May 16, 2018
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk AssessmentTara M Babu, Ranawaka A P M Perera, Joseph T Wu, et al.
Vaccine: X|January 31, 2025
Influenza vaccine effectiveness against influenza-associated hospitalizations in children, Hong Kong, November 2023 to June 2024So-Lun Lee, Mike Y W Kwan, Caitriona Murphy, et al.
Vaccine|February 23, 2024
Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023Caitriona Murphy, Mike Y W Kwan, Eunice L Y Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza BBenjamin J Cowling, Wey Wen Lim, Ranawaka A P M Perera, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2015
International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEKaren L Laurie, Othmar G Engelhardt, John Wood, et al.
FEBS Letters|September 23, 2006
Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunitFanya Zeng, Chung Chau Hon, Chi Wai Yip, et al.
The Journal of Biological Chemistry|November 23, 2011
Class II ADP-ribosylation factors are required for efficient secretion of dengue virusesMateusz Kudelko, Jean-Baptiste Brault, Kevin Kwok, et al.
Pageof 67

Showing results (201-210 of 661) with videos related to

Sort By:
Pageof 67
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 14, 2017
Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017Min Kang, Eric H Y Lau, Wenda Guan, et al.
Emerging Infectious Diseases|February 7, 2008
Poultry drinking water used for avian influenza surveillanceY H Connie Leung, Li-Juan Zhang, Chun-Kin Chow, et al.
Frontiers in Veterinary Science|October 21, 2016
MERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion ElicitationAnna L Funk, Flavie Luce Goutard, Eve Miguel, et al.
The Journal of Infectious Diseases|May 16, 2018
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk AssessmentTara M Babu, Ranawaka A P M Perera, Joseph T Wu, et al.
Vaccine: X|January 31, 2025
Influenza vaccine effectiveness against influenza-associated hospitalizations in children, Hong Kong, November 2023 to June 2024So-Lun Lee, Mike Y W Kwan, Caitriona Murphy, et al.
Vaccine|February 23, 2024
Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023Caitriona Murphy, Mike Y W Kwan, Eunice L Y Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza BBenjamin J Cowling, Wey Wen Lim, Ranawaka A P M Perera, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2015
International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEKaren L Laurie, Othmar G Engelhardt, John Wood, et al.
FEBS Letters|September 23, 2006
Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunitFanya Zeng, Chung Chau Hon, Chi Wai Yip, et al.
The Journal of Biological Chemistry|November 23, 2011
Class II ADP-ribosylation factors are required for efficient secretion of dengue virusesMateusz Kudelko, Jean-Baptiste Brault, Kevin Kwok, et al.
Pageof 67